| Autor: |
Minamitani T; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Kiyose K; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Otsubo R; Laboratory of Pharmaceutical Integrated Omics, Department of Pharmaceutical Engineering, Facility of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan., Ito T; Laboratory of Proteome Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Akiba H; Laboratory of Advanced Biopharmaceuticals, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan., Furuta RA; Japanese Red Cross Central Blood Institute, 1-67 Tatsumi, Koto-ku, Tokyo, 135-8521, Japan., Inoue T; Division of Advance Pharmaco-Science, Graduate School of Pharmaceutical Science, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan., Tsumoto K; Center for Drug Discovery Research (CDDR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan.; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.; Department of Bioengineering, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8656, Japan., Satake M; Japanese Red Cross Central Blood Institute, 1-67 Tatsumi, Koto-ku, Tokyo, 135-8521, Japan., Yasui T; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan. tyasui@nibiohn.go.jp.; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka, 567-0085, Japan. tyasui@nibiohn.go.jp.; Laboratory of Pharmaceutical Integrated Omics, Department of Pharmaceutical Engineering, Facility of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan. tyasui@nibiohn.go.jp. |
